Back to Journals » Pharmacogenomics and Personalized Medicine

Pharmacogenomics and Personalized Medicine

ISSN: 1178-7066

Editor-in-Chief: Dr Martin H Bluth

An international, peer-reviewed, open-access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability. 

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE). 

We are currently seeking expressions of interest for an Associate Editor position and for Editorial Board members for this journal.
Please send your CV and a one-page vision statement detailing your overall objectives for the journal to Emi Kirilova - [email protected]. Please be sure to indicate whether you are interested in the Associate Editor role or a position on the Editorial Board in your application.

Latest articles:

- 5 records -

Novel Autophagy-Related Blood Biomarkers Associated with Immune Cell Infiltration in Ankylosing Spondylitis

Song H, Liu H, Li X, Lv B, Tang Z, Chen Q, Zhang D, Wang F

Pharmacogenomics and Personalized Medicine 2023, 16:1055-1066

Published Date: 5 December 2023

Identification of P3H1 as a Predictive Prognostic Biomarker for Bladder Urothelial Carcinoma Based on the Cancer Genome Atlas Database

Zhang Y, Chen Y, Chen Z, Zhou X, Chen S, Lan K, Wang Z, Zhang Y

Pharmacogenomics and Personalized Medicine 2023, 16:1041-1053

Published Date: 1 December 2023

Read more articles